In the rapidly evolving landscape of metabolic medicine, Eli Lilly has positioned itself at the vanguard with...
Asep Darmawan
HUNTSVILLE, ALABAMA — In an era where national security is increasingly defined by technological superiority and biological...
In the high-stakes world of global technology, financial earnings reports are rearview mirrors—accurate, but fundamentally historical. For...
The scientific community, McMaster University, and the global oncology research landscape are mourning the profound loss of...
OTTAWA – As the federal government prepares the upcoming budget, Breast Cancer Canada (BCC) has issued a...
In the traditional landscape of small-molecule drug discovery, the timeline is often dictated by a rigid, linear...
Main Facts: A Challenging Outcome for Novel Glioblastoma Therapy In a significant blow to its clinical development...
NEW ORLEANS – In a significant transition for the field of reconstructive medicine, Babak J. Mehrara, MD,...
In the landscape of 21st-century biomedicine, few institutions have exerted as profound an influence on human health...
The landscape of breast cancer treatment is undergoing a seismic shift. For decades, the standard of care...
